Prof Michael Woodward AM

Neurology

Podcasts

Dementia at the frontline: New tests and treatments – Expert panel

A timely expert discussion on how new dementia diagnostics and therapies are reshaping primary care.

Diet and nutrition, Geriatric medicine, Neurology

Videos

The role of a medical food (Souvenaid) in the management of patients with early Alzheimer’s disease including mild cognitive impairment

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

Infectious diseases

Podcasts

Using the new RSV vaccine in practice

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Infectious diseases

Podcasts

Adult vaccination – What’s new? – Lecture

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

Drugs and devices, Geriatric medicine, Infectious diseases, Vaccination

Videos

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

Infectious diseases

Podcasts

RSV – A serious adult disease worth preventing

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

Immunology and allergy, Infectious diseases

Videos

Recombinant herpes zoster vaccine – Now on the NIP

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.

Infectious diseases

Podcasts

The burden of shingles – Facts and common myths

We have two VZ vaccines both quite different in terms of efficacy, duration of protection, costs, contraindications, and dosing schedules

Neurology

Podcasts

Mild cognitive impairment – Detection & diagnosis: Part 1

The importance of accurately diagnosing mild cognitive impairment early

Diet and nutrition, Geriatric medicine, Neurology

Videos

Souvenaid – the role of a medical food to support memory and cognitive function in patients in the early stages of alzheimer’s disease

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

Geriatric medicine, Neurology

Podcasts

Strategies to mitigate cognitive decline and early dementia

Latest evidence-based recommendations on how people can preserve their cognitive function as they age, and slow the progression to dementia.

Geriatric medicine

Monographs

Closing the Immunisation Gap in Older Australians

This article discusses how GPs can improve the vaccination coverage among older Australians which is currently poor despite the ready availability, safety and effectiveness of these vaccines. Written by A/Prof Michael Woodward AM, MB, BS, MD, FRACP, and A/Prof John Litt MB, BS, DRACOG, MSc(Epid), FRACP, FAFPHM, PhD

Prof Michael Woodward AM

Geriatrician; Head of Aged Care and Memory Clinic, Austin Health

More from this expert

A timely expert discussion on how new dementia diagnostics and therapies are reshaping primary care.

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.

We have two VZ vaccines both quite different in terms of efficacy, duration of protection, costs, contraindications, and dosing schedules

The importance of accurately diagnosing mild cognitive impairment early

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

Latest evidence-based recommendations on how people can preserve their cognitive function as they age, and slow the progression to dementia.

Latest evidence-based recommendations on how people can preserve their cognitive function as they age, and slow the progression to dementia.

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

The importance of accurately diagnosing mild cognitive impairment early

We have two VZ vaccines both quite different in terms of efficacy, duration of protection, costs, contraindications, and dosing schedules

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.

In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

A/Prof Michael Woodward AM outlines the challenges associated with getting older people optimally protected.

In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).

A timely expert discussion on how new dementia diagnostics and therapies are reshaping primary care.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Last chance - $155 special ends midnight Sunday!

This is your last chance to secure discounted registration to both national seminars before prices increase on Monday! You're invited to attend Australia's most popular seminars for GPs and healthcare professionals.

First Healthed Webcast for 2026

TONIGHT! The new dementia test - Assessment & management of the patient with cognitive concerns

Tuesday 3rd February, 7pm - 9pm AEDT

Speaker

Dr Stephanie Daly

General Practitioner; GP Educator, Dementia Training Australia; Central Adelaide Multi-Disciplinary Geriatric Service, SA Health

We invite you to our first webcast of 2026, where Dr Stephanie Daly​ will provide an update on dementia tests in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

We invite you to our first webcast of 2026, where Dr Stephanie Daly will provide an update on dementia tests in primary care. Earn up to 4 hours CPD. RACGP & ACRRM accredited.